Latest Insider Transactions at Envista Holdings Corp (NVST)
This section provides a real-time view of insider transactions for Envista Holdings Corp (NVST). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Envista Holdings Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Envista Holdings Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 01
2024
|
Paul A Keel Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
53,996
-13.41%
|
$1,079,920
$20.94 P/Share
|
|
Sep 17
2024
|
Mischa Reis SVP, Strategy & Bus. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
812
-1.87%
|
$15,428
$19.0 P/Share
|
|
Aug 25
2024
|
Robert Befidi President, Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
3,454
-7.99%
|
$62,172
$18.7 P/Share
|
|
Aug 25
2024
|
Eric D. Hammes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
64,175
+41.98%
|
-
|
|
Aug 13
2024
|
Paul A Keel Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
30,000
+6.93%
|
$480,000
$16.87 P/Share
|
|
Aug 12
2024
|
Eric D. Hammes Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
24,532
+50.0%
|
$392,512
$16.33 P/Share
|
|
Jul 15
2024
|
Mark E Nance General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
491
-0.85%
|
$7,365
$15.94 P/Share
|
|
Jun 25
2024
|
Stephen Keller Principal Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
31,250
+36.74%
|
-
|
|
May 25
2024
|
Paul A Keel Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
372,605
+47.36%
|
-
|
|
May 25
2024
|
Eric Conley SVP, Orthodontics |
SELL
Payment of exercise price or tax liability
|
Direct |
642
-1.19%
|
$11,556
$18.25 P/Share
|
|
May 21
2024
|
Christine A Tsingos Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,085
+20.08%
|
-
|
|
May 21
2024
|
Vivek Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,085
+23.32%
|
-
|
|
May 21
2024
|
R Scott Huennekens Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,170
+20.44%
|
-
|
|
May 21
2024
|
Barbara B. Hulit Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,085
+12.69%
|
-
|
|
May 21
2024
|
Daniel Raskas Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,085
+22.76%
|
-
|
|
May 21
2024
|
Wendy Carruthers Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,085
+20.07%
|
-
|
|
May 21
2024
|
Kieran Gallahue Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,085
+22.76%
|
-
|
|
Apr 15
2024
|
Barbara B. Hulit Director |
BUY
Grant, award, or other acquisition
|
Direct |
13,065
+18.06%
|
-
|
|
Mar 15
2024
|
Barbara B. Hulit Director |
BUY
Grant, award, or other acquisition
|
Direct |
11,705
+20.21%
|
-
|
|
Feb 25
2024
|
Amir Aghdaei Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
48,570
+13.52%
|
-
|
|
Feb 25
2024
|
Amir Aghdaei Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
33,367
-11.3%
|
$734,074
$22.65 P/Share
|
|
Feb 25
2024
|
Eric Conley SVP, Orthodontics |
BUY
Grant, award, or other acquisition
|
Direct |
7,730
+12.55%
|
-
|
|
Feb 25
2024
|
Eric Conley SVP, Orthodontics |
SELL
Payment of exercise price or tax liability
|
Direct |
1,241
-2.62%
|
$27,302
$22.65 P/Share
|
|
Feb 25
2024
|
Robert Befidi President, Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
9,385
+17.83%
|
-
|
|
Feb 25
2024
|
Mischa Reis SVP, Strategy & Bus. Dev. |
BUY
Grant, award, or other acquisition
|
Direct |
16,565
+27.56%
|
-
|
|
Feb 25
2024
|
Mischa Reis SVP, Strategy & Bus. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
4,134
-13.29%
|
$90,948
$22.65 P/Share
|
|
Feb 25
2024
|
Stephen Keller Principal Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,045
+32.87%
|
-
|
|
Feb 25
2024
|
Stephen Keller Principal Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,562
-11.95%
|
$34,364
$22.65 P/Share
|
|
Feb 25
2024
|
Mark E Nance General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
21,530
+27.08%
|
-
|
|
Feb 25
2024
|
Mark E Nance General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,600
-6.66%
|
$57,200
$22.65 P/Share
|
|
Feb 25
2024
|
Faez C Kaabi Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
30,915
+40.92%
|
-
|
|
Feb 25
2024
|
Faez C Kaabi Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,505
-9.89%
|
$33,110
$22.65 P/Share
|
|
Feb 15
2024
|
Barbara B. Hulit Director |
BUY
Grant, award, or other acquisition
|
Direct |
22,225
+39.17%
|
-
|
|
Nov 16
2023
|
Eric Conley SVP, Orthodontics |
BUY
Open market or private purchase
|
Direct |
2,185
+1.47%
|
$48,070
$22.9 P/Share
|
|
Nov 08
2023
|
Mark E Nance General Counsel |
BUY
Open market or private purchase
|
Direct |
5,000
+11.35%
|
$105,000
$21.75 P/Share
|
|
Nov 06
2023
|
Amir Aghdaei Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
10,000
+0.83%
|
$210,000
$21.52 P/Share
|
|
Nov 06
2023
|
Stephen Keller Principal Financial Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+13.27%
|
$42,000
$21.53 P/Share
|
|
Sep 17
2023
|
Mischa Reis SVP, Strategy & Bus. Dev. |
SELL
Payment of exercise price or tax liability
|
Direct |
787
-2.47%
|
$22,036
$28.87 P/Share
|
|
Sep 17
2023
|
Howard H Yu Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,965
-4.28%
|
$55,020
$28.87 P/Share
|
|
Sep 17
2023
|
Patrik Eriksson Senior Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,298
-1.6%
|
$36,344
$28.87 P/Share
|
|
Sep 17
2023
|
Amir Aghdaei Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,394
-6.06%
|
$515,032
$28.87 P/Share
|
|
Jul 15
2023
|
Mark E Nance General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
492
-1.42%
|
$17,220
$35.07 P/Share
|
|
Jul 15
2023
|
Amir Aghdaei Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
13,250
-4.18%
|
$463,750
$35.07 P/Share
|
|
May 25
2023
|
Eric Conley SVP, Orthodontics |
SELL
Payment of exercise price or tax liability
|
Direct |
642
-1.4%
|
$20,544
$32.95 P/Share
|
|
May 23
2023
|
R Scott Huennekens Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,625
+15.69%
|
-
|
|
May 23
2023
|
Christine A Tsingos Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,425
+15.29%
|
-
|
|
May 23
2023
|
Vivek Jain Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,425
+19.03%
|
-
|
|
May 23
2023
|
Kieran Gallahue Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,425
+18.35%
|
-
|
|
May 23
2023
|
Wendy Carruthers Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,425
+15.28%
|
-
|
|
May 23
2023
|
Daniel Raskas Director |
BUY
Grant, award, or other acquisition
|
Direct |
5,425
+18.35%
|
-
|